Abstract: A dry powder inhaler includes a chamber holding an actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient. A retaining member prevents the actuator from exiting the chamber. Thus, the medicament may be delivered to the patient without the use of carrier particles.
Type:
Grant
Filed:
December 7, 2011
Date of Patent:
October 22, 2013
Assignee:
Respira Therapeutics, Inc.
Inventors:
Martin Donovan, Jacques Pappo, Hugh Smyth
Abstract: A dry powder inhaler may include a powder storage region, an inlet channel, a dispersion chamber, and an outlet channel. A geometry of the inhaler may be such that a flow profile is generated within the dispersion chamber that causes an actuator to oscillate, enabling the actuator when oscillating to deaggregate powdered medicament within the dispersion chamber to be aerosolized and entrained by the air and delivered to a patient through the outlet channel.
Abstract: A dry powder inhaler includes a chamber holding a bead-like actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The bead-like actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient.
Type:
Application
Filed:
May 11, 2012
Publication date:
November 22, 2012
Applicant:
Respira Therapeutics, Inc.
Inventors:
Martin J. Donovan, Jacques Pappo, Hugh Smyth
Abstract: A dry powder inhaler includes a chamber holding an actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient. A retaining member prevents the actuator from exiting the chamber. Thus, the medicament may be delivered to the patient without the use of carrier particles.
Type:
Application
Filed:
December 7, 2011
Publication date:
June 14, 2012
Applicant:
Respira Therapeutics, Inc.
Inventors:
Martin J. Donovan, Jacques Pappo, Hugh Smyth